Image Credit: STAT News
STAT+: To understand why investors rejoiced at Trump’s attack on drug firms, think like a pharma CEO
President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped loudly and wielded a wet noodle.